U.S. Building Stock News

NYSE:QXO
NYSE:QXOTrade Distributors

QXO (QXO) Q1 2026 Loss Worsens To US$0.31 EPS Challenging Bullish Narratives

QXO (QXO) opened Q1 2026 with total revenue of US$1.7 billion and a basic EPS loss of US$0.31, as net income excluding extra items came in at a loss of US$227.1 million. Over the last five reported quarters, the company has seen revenue move from US$13.5 million in Q1 2025 to US$2.2 billion in Q4 2025 and then to US$1.7 billion in Q1 2026, while quarterly EPS moved from a loss of US$0.03 to a loss of US$0.17 and then to a loss of US$0.31 over the same stretch. For investors, the key focus...
NasdaqGS:NFLX
NasdaqGS:NFLXEntertainment

How Texas’ New Data‑Privacy Lawsuit Against Netflix (NFLX) Has Changed Its Investment Story

In recent days, Texas Attorney General Ken Paxton filed a lawsuit accusing Netflix of illegally collecting and monetizing sensitive user and children’s data without proper consent and of designing its platform to be addictive. The state is seeking civil penalties, data deletion, and limits on targeted advertising, while Netflix calls the claims meritless and says it complies with privacy laws. The suit directly challenges Netflix’s data practices just as it leans more heavily on targeted...
NYSE:DUK
NYSE:DUKElectric Utilities

A Look At Duke Energy (DUK) Valuation After Earnings Beat And Expanded Grid Investment Plan

Duke Energy (DUK) is back in focus after a busy start to May, with Q1 2026 results beating Wall Street expectations, dividends reaffirmed, and fresh financing plans tied to a larger multi year grid investment program. See our latest analysis for Duke Energy. Despite a busy stretch of earnings, capital plan updates and dividend declarations, Duke Energy’s share price has eased in the short term, with the 1 month share price return down about 5%. The 1 year total shareholder return of roughly...
NasdaqGM:OCS
NasdaqGM:OCSPharmaceuticals

A Look At Oculis Holding (OCS) Valuation After Key Phase 3 Clinical Milestones

Oculis Holding (NasdaqGM:OCS) has hit several key clinical milestones, including FDA Special Protocol Assessment agreement for its PIONEER-1 Phase 3 trial of Privosegtor in optic neuritis and completion of critical DIAMOND Phase 3 visits for OCS-01. See our latest analysis for Oculis Holding. Oculis Holding’s recent FDA SPA agreement for PIONEER-1 and progress in its DIAMOND Phase 3 program have come alongside a 56.85% year to date share price return and an 81.54% 1 year total shareholder...
NYSE:GD
NYSE:GDAerospace & Defense

General Dynamics NightDragon Deal Targets Edge In Government Cyber And AI

General Dynamics' GDIT unit has formed a partnership with cybersecurity investment firm NightDragon. The collaboration focuses on bringing commercial artificial intelligence, cybersecurity, and autonomy tools into U.S. government programs. The agreement is intended to speed up government access to emerging security technologies through GDIT's federal customer base. General Dynamics (NYSE:GD) is moving to deepen its role in government technology integration with this GDIT NightDragon...
NYSEAM:ELMD
NYSEAM:ELMDMedical Equipment

Electromed (ELMD) Margin Improvement Reinforces Bullish Earnings Narrative In Q3 2026

Electromed (ELMD) just posted Q3 2026 results with revenue of US$18.6 million and basic EPS of US$0.37, alongside trailing twelve month revenue of US$71.8 million and EPS of US$1.22 that sit against a 41.1% earnings growth rate over the past year. Over recent quarters the company has seen revenue move from US$15.7 million and EPS of US$0.22 in Q3 2025 to US$18.6 million and EPS of US$0.37 in Q3 2026, with trailing net profit margin at 14.1% compared with 11.7% a year earlier. This frames a...
NasdaqGS:LIN
NasdaqGS:LINChemicals

How Linde’s Upgraded 2026 EPS Guidance and Cash Returns Will Impact Linde (LIN) Investors

Linde plc reported past first-quarter 2026 results with sales of US$8,781 million and net income of US$1,857 million, lifting basic earnings per share from continuing operations to US$4.00. The company also raised its full-year 2026 adjusted EPS guidance while returning over US$1.50 billion to shareholders, underlining management’s confidence and cash generation capacity. Next, we’ll examine how this upgraded earnings guidance and strong cash returns may influence Linde’s investment...
NYSE:B
NYSE:BMetals and Mining

Is Barrick Mining (NYSE:B) Share Price Strength Still Supported By Valuation Models

If you are wondering whether Barrick Mining's current share price offers genuine value or just reflects excitement, the recent performance gives you plenty to think about. The stock recently closed at US$44.87, with returns of 7.9% over 7 days, 4.3% over 30 days, 1.8% year to date, 160.6% over 1 year, 161.2% over 3 years and 111.2% over 5 years. Recent coverage around Barrick Mining has focused on its position in the global materials sector and how investors are reacting to that exposure...
NYSE:IRM
NYSE:IRMSpecialized REITs

Assessing Iron Mountain (IRM) Valuation After Strong Multi Year Total Return Performance

Iron Mountain’s recent performance and what it means for investors Iron Mountain (IRM) has attracted fresh attention after a strong run in the stock, with the share price at US$126.12 and total return figures that stand out over the past year and multi year periods. For context, the stock is up over the past month and past 3 months, and its year to date and 1 year total returns are also positive. That kind of momentum often prompts investors to ask whether the current valuation still aligns...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Assessing Analog Devices (ADI) Valuation After Analyst Upgrades And AI Infrastructure Growth Optimism

Analog Devices (ADI) has moved into focus after a series of analyst upgrades linked to demand in AI hardware, industrial automation, and data center infrastructure ahead of its upcoming earnings announcement. See our latest analysis for Analog Devices. The stock’s recent move reflects that momentum has been strong for a while, with a 30 day share price return of 23.54% and a year to date share price return of 57.96%, alongside a 1 year total shareholder return of 93.54% and 5 year total...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Assessing Amneal Pharmaceuticals (AMRX) Valuation After Recent Share Price Weakness

How Amneal Pharmaceuticals Stock Has Been Trading Recently Amneal Pharmaceuticals (AMRX) has been on many investors' radars after a period of mixed share performance, with the stock down over the past week, month, and past 3 months despite a strong 1 year total return. See our latest analysis for Amneal Pharmaceuticals. Recent trading has been choppy, with the share price down over the past week and quarter, yet the 1 year and multi year total shareholder returns remain strong. This suggests...
NasdaqGS:DIOD
NasdaqGS:DIODSemiconductor

Diodes Board Shift Raises Questions On Capital Allocation And Growth Focus

Diodes Incorporated (NasdaqGS:DIOD) announced the retirement of longtime Chairman Dr. Keh-Shew Lu after more than 25 years with the company. The board elected Angie Chen Button as the new Chairwoman of the Board, marking a significant leadership change at Diodes. This transition closes a chapter in which Diodes evolved from a mid-sized business into a global semiconductor company. Diodes focuses on semiconductor products that sit behind many everyday electronics, with exposure to...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

GitLab Restructuring For Agentic AI Era Tests Execution And Valuation

GitLab (NasdaqGS:GTLB) has announced a major global restructuring and workforce reduction aimed at repositioning the company for what it calls the agentic AI era. The plan includes country exits, a flatter management structure, and a shift to smaller autonomous teams focused on AI driven software development. GitLab intends to reinvest cost savings from the restructuring into AI infrastructure and an AI centric engineering operating model referred to internally as Act 2. The company has...
NYSE:DAN
NYSE:DANAuto Components

Is It Too Late To Consider Dana (DAN) After A 108% One Year Surge?

If you are wondering whether Dana's share price still offers value after a strong run, it helps to step back and look at what the current market price might be implying about the business. The stock has pulled back over the last week and month, declining 3.7% over 7 days and 6.5% over 30 days, yet it is still up 37.4% year to date and 108.2% over the past year. Recent coverage around Dana has focused on its role in the Auto Components sector and how investors are reacting to that...
NYSE:JPM
NYSE:JPMBanks

Assessing JPMorgan Chase (JPM) Valuation After Recent Share Price Weakness

JPMorgan Chase stock in focus JPMorgan Chase (JPM) is back on investors’ radar after recent share price weakness, with the stock down 4.3% over the past month and 0.8% over the past 3 months from its last close of US$300.25. See our latest analysis for JPMorgan Chase. Recent share price momentum has cooled, with the stock down 7.8% year to date, even though the 1 year total shareholder return of 15.2% and very large 3 year total shareholder return of about 13x point to a stronger longer...
NYSE:FICO
NYSE:FICOSoftware

Is There Now An Opportunity In Fair Isaac (FICO) After A 50% One-Year Slump?

For readers wondering whether Fair Isaac, at around US$1,064 per share, is now a bargain or still richly priced, this article walks through what the numbers indicate about the stock's value. The share price has been relatively flat over the last 7 days, edging down 0.2%. It has risen 6.4% over the past month while still sitting well below its levels from earlier in the year, with the stock down 35.2% year to date and 49.9% over the last 12 months. These moves come as investors reassess Fair...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Does Tempus AI’s (TEM) Zero-Coupon Convertible Note Clarify Its Path in AI Diagnostics?

In early May 2026, Tempus AI completed a US$400 million zero-coupon, senior unsecured convertible note offering due 2032 under Rule 144A, shortly after reporting first-quarter revenue of US$348.12 million and a wider net loss of US$125.92 million alongside higher full-year 2026 guidance. At the same time, the company deepened its role in precision medicine through a Lucent Diagnostics collaboration on Alzheimer’s blood-based biomarkers and industry recognition for Ambry Genetics’ CARE...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

A Look At Mercury Systems (MRCY) Valuation After Earnings Show Higher Sales And A Smaller Net Loss

Mercury Systems (MRCY) has drawn fresh attention after reporting third quarter and nine month results to March 27, 2026, with higher sales and a sharply reduced net loss compared with a year earlier. See our latest analysis for Mercury Systems. The latest results appear to have reinforced a recovery story in the stock, with a 30 day share price return of 12.09% and a 1 year total shareholder return of 106.11%, suggesting momentum has been building over time. If these results have you looking...
NYSE:VLO
NYSE:VLOOil and Gas

Did Valero’s Return to Profit and Steady Dividend Just Shift Valero Energy's (VLO) Investment Narrative?

Valero Energy Corporation recently reported first-quarter 2026 results, with sales of US$30,656 million and net income of US$1,263 million, and its board declared a regular quarterly cash dividend of US$1.20 per share payable on June 23, 2026 to shareholders of record on May 21, 2026. These results mark a shift from a net loss in the prior-year quarter while the maintained dividend and director stock unit awards highlight management’s emphasis on consistent capital returns and governance...
NasdaqGS:CME
NasdaqGS:CMECapital Markets

How CME’s GPU-Based Compute Futures Plan Will Impact CME Group (CME) Investors

CME Group and Silicon Data have already announced plans to launch a first-in-class compute futures market later in 2026, pending regulatory review, using Silicon Data’s daily GPU rental-rate indices to bring standardized pricing and risk management to the multi-trillion-dollar compute market. This move effectively treats computing power as a tradable asset class, potentially reshaping how AI builders, cloud providers and financial institutions plan and hedge long-term infrastructure...
NYSE:JBL
NYSE:JBLElectronic

Is It Too Late To Consider Jabil (JBL) After Doubling In The Past Year?

If you are wondering whether Jabil's current share price offers value or is getting ahead of itself, the recent performance gives plenty to think about. The stock closed at US$355.43, with the price falling 4.5% over the last week but rising 16.4% over the past month, 47.9% year to date and 113.3% over the last year, while the three year and five year returns are very large. Recent news around Jabil has focused on providing ongoing coverage of the stock for investors, keeping attention on...
NYSE:ACM
NYSE:ACMConstruction

Aecom (ACM) Q2 EPS Record Reinforces Bullish Margin Expansion Narrative

AECOM's Q2 2026 earnings snapshot AECOM (ACM) has released its Q2 2026 results, reporting revenue of US$3.8 billion and basic EPS of US$1.43, alongside trailing 12 month net income from continuing operations of US$631.3 million. Over recent quarters, the company has seen quarterly revenue move between US$3.8 billion and US$4.2 billion, while basic EPS has ranged from US$0.99 to US$1.43, giving investors a clear read on how earnings track against a trailing 12 month EPS of US$4.82. With a...
NYSE:JBI
NYSE:JBIBuilding

Janus International Group Q1 EPS Collapse Tests Bullish Margin Expansion Narrative

Janus International Group (JBI) has reported Q1 2026 revenue of US$222.7 million with basic EPS of about US$0.00, alongside trailing twelve month revenue of US$896.4 million and EPS of US$0.31, against a backdrop of trailing net profit margin at 4.8% compared with 5.4% a year earlier. Over the past year, revenue has moved from US$963.8 million to US$896.4 million on a trailing basis as EPS shifted from US$0.49 to US$0.31. Investors are weighing forecast earnings growth of about 15.1% a year...
NasdaqGS:XEL
NasdaqGS:XELElectric Utilities

Assessing Xcel Energy (XEL) Valuation After Q1 Earnings, Guidance Reaffirmation And New Google Data Center Agreement

Xcel Energy (XEL) is in focus after reporting first quarter 2026 earnings, reaffirming its full year EPS guidance of $4.04 to $4.16 and signing a new Google data center power agreement. See our latest analysis for Xcel Energy. Recent news, including the Google data center agreement, Q1 2026 earnings and a planned US$4.3b follow on equity offering, comes as Xcel Energy’s share price return has gained 7% year to date. The 1 year total shareholder return sits at 19.82% and the 3 year total...